- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Aerobic Exercise Improves Chemotherapy-Induced Peripheral Neuropathy: JAMA
![Aerobic Exercise Improves Chemotherapy-Induced Peripheral Neuropathy: JAMA Aerobic Exercise Improves Chemotherapy-Induced Peripheral Neuropathy: JAMA](https://medicaldialogues.in/h-upload/2023/03/01/750x450_203581-diabetic-neuropathy.webp)
Chemotherapy-induced peripheral neuropathy (CIPN) is a distressing side effect experienced by many cancer patients, specially in ovarian cancer survivors. The condition can severely impact the quality of life for survivors, yet there has been no effective treatment available to alleviate its symptoms. A recent analysis of the Women's Activity and Lifestyle Study in Connecticut (WALC) published in the Journal American Medical Association has shown promising results in managing CIPN through a 6-month aerobic exercise intervention.
The WALC study, a multicentered, open-label, phase 3 randomized clinical trial, aimed to evaluate the effects of aerobic exercise on CIPN among women who had undergone chemotherapy for ovarian cancer. The study randomly assigned 134 participants, all females with an average age of 57.5 years, to either a 6-month aerobic exercise intervention or an attention control group. The exercise intervention involved home-based moderate-intensity aerobic exercises, guided by weekly telephone counseling from certified cancer exercise trainers. The attention control group received weekly health education telephone calls from WALC staff members.
The primary outcome of the analysis was the change in CIPN severity, as self-measured by the participants at baseline and after the 6-month intervention using the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group–Neurotoxicity scale.
The results were significant, demonstrating a notable improvement in self-reported CIPN scores among participants in the exercise intervention arm. At the 6-month mark, the exercise group reported a reduction of 1.3 points in CIPN scores, while the attention control group saw an increase of 0.4 points. The difference between the two groups was statistically significant at -1.6 points, indicating that the exercise intervention led to a positive impact on managing CIPN symptoms.
Furthermore, the analysis highlighted that the exercise intervention's effects were more pronounced in patients who had experienced CIPN symptoms at enrollment. Among these patients, the exercise intervention resulted in a reduction of 2.0 points in CIPN scores.
Source:
Cao, A., Cartmel, B., Li, F.-Y., Gottlieb, L. T., Harrigan, M., Ligibel, J. A., Gogoi, R., Schwartz, P. E., Esserman, D. A., Irwin, M. L., & Ferrucci, L. M. (2023). Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy Among Patients Treated for Ovarian Cancer. In JAMA Network Open (Vol. 6, Issue 8, p. e2326463). American Medical Association (AMA). https://doi.org/10.1001/jamanetworkopen.2023.26463
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: editorial@medicaldialogues.in. Contact no. 011-43720751